StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report released on Monday. The brokerage issued a sell rating on the stock.
Navidea Biopharmaceuticals Stock Performance
Shares of NYSE:NAVB opened at $0.00 on Monday. Navidea Biopharmaceuticals has a 1-year low of $0.00 and a 1-year high of $0.15. The firm has a market capitalization of $20,016.00, a PE ratio of 0.00 and a beta of 0.75. The business’s 50 day moving average is $0.03 and its 200-day moving average is $0.04.
Navidea Biopharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Navidea Biopharmaceuticals
- 3 Stocks to Consider Buying in October
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- Ride Out The Recession With These Dividend Kings
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- What is MarketRank™? How to Use it
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for Navidea Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.